News article

The latest stories about hormones
Setmelanotide trial data shows promise for treatment of obesity

Setmelanotide trial data shows promise for treatment of obesity

30 Sept 2021


Clinical trial data, presented by Rhythm Pharmaceuticals at the 59th Annual European Society for Paediatric Endocrinology Meeting, indicates that setmelanotide has efficacy in treating rare genetic causes of obesity.

Yahoo

Contents